Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protein kinase C, epsilon | Starlite/ChEMBL | References |
Homo sapiens | protein kinase C, theta | Starlite/ChEMBL | References |
Homo sapiens | protein kinase C, beta | Starlite/ChEMBL | References |
Homo sapiens | protein kinase C, delta | Starlite/ChEMBL | References |
Homo sapiens | protein kinase C, alpha | Starlite/ChEMBL | References |
Homo sapiens | protein kinase C, eta | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0216 | 0.3952 | 0.6281 |
Loa Loa (eye worm) | hypothetical protein | 0.0333 | 0.7801 | 0.7801 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0103 | 0.0246 | 0.0246 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0168 | 0.2397 | 0.381 |
Echinococcus multilocularis | serine:threonine protein kinase N2 | 0.0234 | 0.4539 | 0.7214 |
Loa Loa (eye worm) | hypothetical protein | 0.0143 | 0.1555 | 0.1555 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0287 | 0.6292 | 1 |
Echinococcus granulosus | protein kinase c iota type | 0.0115 | 0.0633 | 0.1006 |
Onchocerca volvulus | 0.0333 | 0.7801 | 0.5 | |
Schistosoma mansoni | serine/threonine protein kinase | 0.0216 | 0.3952 | 0.5865 |
Loa Loa (eye worm) | hypothetical protein | 0.0333 | 0.7801 | 0.7801 |
Brugia malayi | protein kinase C II. | 0.0287 | 0.6292 | 1 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0287 | 0.6292 | 0.6292 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0287 | 0.6292 | 1 |
Echinococcus multilocularis | protein kinase c iota type | 0.0115 | 0.0633 | 0.1006 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0168 | 0.2388 | 0.5 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.0216 | 0.3952 | 0.6281 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0216 | 0.3952 | 0.5865 |
Echinococcus granulosus | protein kinase C gamma type | 0.0168 | 0.2397 | 0.381 |
Loa Loa (eye worm) | hypothetical protein | 0.0381 | 0.9356 | 0.9356 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0287 | 0.6292 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0333 | 0.7801 | 0.7801 |
Echinococcus granulosus | serine:threonine protein kinase N2 | 0.0168 | 0.2388 | 0.3795 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 403 nM | Inhibition of recombinant human PKCepsilon assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay | ChEMBL. | 22078216 |
IC50 (binding) | = 452 nM | Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay | ChEMBL. | 22078216 |
IC50 (binding) | = 818 nM | Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay | ChEMBL. | 22078216 |
IC50 (binding) | = 932 nM | Inhibition of recombinant human PKCdelta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay | ChEMBL. | 22078216 |
IC50 (binding) | > 1000 nM | Inhibition of recombinant human PKCbeta1 assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay | ChEMBL. | 22078216 |
IC50 (binding) | > 1000 nM | Inhibition of recombinant human PKCtheta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay | ChEMBL. | 22078216 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.